CENCORA, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
CENCORA, INC. (COR) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $776.67 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-05
- CENCORA, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $776.67M, a 12.60% increase year-over-year.
- CENCORA, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $1.63B, a 127.14% increase year-over-year.
- CENCORA, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $566.13M, a 14.67% increase year-over-year.
- CENCORA, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$333.07M, a 4561.17% decline year-over-year.
- CENCORA, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was $1.67B, a 7.89% increase from fiscal 2021.
- CENCORA, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was $1.54B.
- CENCORA, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$3.40B, a 498.01% decline from fiscal 2019.
- CENCORA, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was $854.13M, a 47.14% decline from fiscal 2018.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $776.67M 10-Q · filed 2026-08-05 | $2.41B derived: sum of 2 quarters · filed 2026-08-05 | $2.97B 10-Q · filed 2026-08-05 | $2.64B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.63B 10-Q · filed 2026-05-06 | $2.20B 10-Q · filed 2026-05-06 | $1.86B derived: sum of 3 quarters · filed 2026-05-06 | $2.55B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $566.13M 10-Q · filed 2026-02-04 | $233.06M derived: sum of 2 quarters · filed 2026-02-10 | $922.80M derived: sum of 3 quarters · filed 2026-08-05 | $1.64B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-09-30 | -$333.07M derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $356.68M derived: sum of 2 quarters · filed 2026-08-05 | $1.07B derived: sum of 3 quarters · filed 2026-08-05 | $1.57B 8-K · filed 2026-02-10 |
| 2025-06-30 | $689.75M 10-Q · filed 2026-08-05 | $1.41B derived: sum of 2 quarters · filed 2026-08-05 | $1.90B 10-Q · filed 2026-08-05 | $1.91B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $717.42M 10-Q · filed 2026-05-06 | $1.21B 10-Q · filed 2026-05-06 | $1.22B derived: sum of 3 quarters · filed 2026-05-06 | $1.71B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $493.72M 10-Q · filed 2026-02-04 | $501.19M derived: sum of 2 quarters · filed 2026-02-10 | $988.78M derived: sum of 3 quarters · filed 2026-02-10 | $1.41B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | $7.47M derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $495.06M derived: sum of 2 quarters · filed 2026-02-10 | $916.26M derived: sum of 3 quarters · filed 2026-02-10 | $1.52B 8-K · filed 2026-02-10 |
| 2024-06-30 | $487.59M 10-Q · filed 2025-08-06 | $908.80M derived: sum of 2 quarters · filed 2025-08-06 | $1.51B 10-Q · filed 2025-08-06 | $1.86B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $421.20M 10-Q · filed 2025-05-07 | $1.02B 10-Q · filed 2025-05-07 | $1.37B derived: sum of 3 quarters · filed 2026-02-10 | $1.85B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $603.01M 10-Q · filed 2025-02-05 | $951.99M derived: sum of 2 quarters · filed 2026-02-10 | $1.43B derived: sum of 3 quarters · filed 2026-02-10 | $1.86B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-09-30 | $348.98M derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $828.19M derived: sum of 2 quarters · filed 2026-02-10 | $1.26B derived: sum of 3 quarters · filed 2026-02-10 | $1.73B 8-K · filed 2026-02-10 |
| 2023-06-30 | $479.21M 10-Q · filed 2024-07-31 | $907.43M derived: sum of 2 quarters · filed 2024-07-31 | $1.38B 10-Q · filed 2024-07-31 | $1.68B derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-03-31 | $428.21M 10-Q · filed 2024-05-01 | $904.38M 10-Q · filed 2024-05-01 | $1.20B derived: sum of 3 quarters · filed 2024-11-26 | $1.57B derived: sum of 4 quarters · filed 2024-11-26 |
| 2022-12-31 | $476.17M 10-Q · filed 2024-01-31 | $774.85M derived: sum of 2 quarters · filed 2024-11-26 | $1.14B derived: sum of 3 quarters · filed 2024-11-26 | $1.69B derived: sum of 4 quarters · filed 2024-11-26 |
| 2022-09-30 | $298.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $661.88M derived: sum of 2 quarters · filed 2024-11-26 | $1.22B derived: sum of 3 quarters · filed 2024-11-26 | $1.67B 10-K · filed 2024-11-26 |
| 2022-06-30 | $363.20M 10-Q · filed 2023-08-02 | $918.45M derived: sum of 2 quarters · filed 2023-08-02 | $1.37B 10-Q · filed 2023-08-02 | $1.80B derived: sum of 4 quarters · filed 2023-11-21 |
| 2022-03-31 | $555.25M 10-Q · filed 2023-05-02 | $1.00B 10-Q · filed 2023-05-02 | $1.44B derived: sum of 3 quarters · filed 2023-11-21 | $1.74B derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-12-31 | $449.42M 10-Q · filed 2023-02-01 | $885.86M derived: sum of 2 quarters · filed 2023-11-21 | $1.18B derived: sum of 3 quarters · filed 2023-11-21 | $1.62B derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-09-30 | $436.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $731.90M derived: sum of 2 quarters · filed 2023-11-21 | $1.17B derived: sum of 3 quarters · filed 2023-11-21 | $1.54B 10-K · filed 2023-11-21 |
| 2021-06-30 | $295.45M 10-Q · filed 2022-08-03 | $729.45M derived: sum of 2 quarters · filed 2022-08-03 | $1.11B 10-Q · filed 2022-08-03 | -$3.74B derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $434.00M 10-Q · filed 2022-05-04 | $812.71M 10-Q · filed 2022-05-04 | -$4.03B derived: sum of 3 quarters · filed 2022-05-04 | -$3.74B derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $378.71M 10-Q · filed 2022-02-02 | -$4.47B derived: sum of 2 quarters · filed 2022-02-02 | -$4.18B derived: sum of 3 quarters · filed 2022-02-02 | -$3.21B derived: sum of 4 quarters · filed 2022-02-02 |
| 2020-09-30 | -$4.84B 10-K · filed 2020-11-19 | -$4.56B derived: sum of 2 quarters · filed 2021-08-04 | -$3.59B derived: sum of 3 quarters · filed 2021-08-04 | -$3.40B 10-K · filed 2022-11-22 |
| 2020-06-30 | $287.27M 10-Q · filed 2021-08-04 | $1.26B derived: sum of 2 quarters · filed 2021-08-04 | $1.44B 10-Q · filed 2021-08-04 | $1.58B derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $971.11M 10-Q · filed 2021-05-05 | $1.16B 10-Q · filed 2021-05-05 | $1.29B derived: sum of 3 quarters · filed 2021-05-05 | $1.59B derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $186.57M 10-Q · filed 2021-02-04 | $318.88M derived: sum of 2 quarters · filed 2021-02-04 | $620.88M derived: sum of 3 quarters · filed 2021-02-04 | $648.95M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $132.31M 10-K · filed 2020-11-19 | $434.31M derived: sum of 2 quarters · filed 2020-11-19 | $462.38M derived: sum of 3 quarters · filed 2020-11-19 | $854.13M 10-K · filed 2021-11-23 |
| 2019-06-30 | $302.00M 10-K · filed 2020-11-19 | $330.07M derived: sum of 2 quarters · filed 2020-11-19 | $721.83M 10-Q · filed 2020-08-05 | $915.83M derived: sum of 4 quarters · filed 2020-11-19 |
| 2019-03-31 | $28.07M 10-K · filed 2020-11-19 | $419.83M 10-Q · filed 2020-05-07 | $613.83M derived: sum of 3 quarters · filed 2020-11-19 | $891.71M derived: sum of 4 quarters · filed 2020-11-19 |
| 2018-12-31 | $391.75M 10-K · filed 2020-11-19 | $585.76M derived: sum of 2 quarters · filed 2020-11-19 | $863.63M derived: sum of 3 quarters · filed 2020-11-19 | $1.15B derived: sum of 4 quarters · filed 2020-11-19 |
| 2018-09-30 | $194.00M 10-K · filed 2019-11-19 | $471.88M derived: sum of 2 quarters · filed 2019-11-19 | $754.04M derived: sum of 3 quarters · filed 2019-11-19 | $1.62B 10-K · filed 2020-11-19 |
| 2018-06-30 | $277.88M 10-K · filed 2019-11-19 | $560.03M derived: sum of 2 quarters · filed 2019-11-19 | $1.42B 10-Q · filed 2019-08-01 | $1.08B derived: sum of 4 quarters · filed 2019-11-19 |
| 2018-03-31 | $282.16M 10-K · filed 2019-11-19 | $1.14B 10-Q · filed 2019-05-02 | $799.43M derived: sum of 3 quarters · filed 2019-11-19 | $849.78M derived: sum of 4 quarters · filed 2019-11-19 |
| 2017-12-31 | $861.85M 10-K · filed 2019-11-19 | $517.27M derived: sum of 2 quarters · filed 2019-11-19 | $567.62M derived: sum of 3 quarters · filed 2019-11-19 | $979.09M derived: sum of 4 quarters · filed 2019-11-19 |
| 2017-09-30 | -$344.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-19 | -$294.24M derived: sum of 2 quarters · filed 2019-11-19 | $117.24M derived: sum of 3 quarters · filed 2019-11-19 | $364.48M 10-K · filed 2019-11-19 |
| 2017-06-30 | $50.35M 10-Q · filed 2018-08-02 | $461.82M derived: sum of 2 quarters · filed 2018-08-02 | $709.07M 10-Q · filed 2018-08-02 | |
| 2017-03-31 | $411.47M 10-Q · filed 2018-05-02 | $658.72M 10-Q · filed 2018-05-02 | ||
| 2016-09-30 | $1.43B 10-K · filed 2018-11-20 | |||
| 2009-06-30 | $118.81M 10-Q · filed 2009-08-06 | $373.25M 10-Q · filed 2009-08-06 | ||
| 2008-06-30 | -$108.02M 10-Q · filed 2009-08-06 | $135.65M 10-Q · filed 2009-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |